CACNA2D1
MOLECULAR TARGETcalcium voltage-gated channel auxiliary subunit alpha2delta 1
CACNA2D1 (calcium voltage-gated channel auxiliary subunit alpha2delta 1) is targeted by 4 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting CACNA2D1
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | Gabapentin | 1.61 | 4 |
| 2 | Pregabalin | 1.39 | 3 |
| 3 | Ethionine 2-Amino-4-(ethylthio)butyric acid. | 1.10 | 2 |
| 4 | Flunarizine Flunarizine is | 0.69 | 1 |
About CACNA2D1 as a Drug Target
CACNA2D1 (calcium voltage-gated channel auxiliary subunit alpha2delta 1) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 4 compounds with documented CACNA2D1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
CACNA2D1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.